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Escherichia coli 83972 is a clinical asymptomatia bacteriuric isolate that is able to colonize the human
urinary bladder without inducing an immune response. Here we demonstrate that one of the mechanisms by
which this strain has become attenuated is through the mutation of its genes encoding type 1 and P fimbriae.
Urinary tract infections (UTI) are among the most common
infectious diseases of humans and a major cause of morbidity
and mortality. Acute pyelonephritis and asymptomatic bacte-
riuria (ABU) represent the two extremes of UTI. Acute pye-
lonephritis is a severe systemic infection caused by uropatho-
genic Escherichia coli (UPEC) (6, 7, 29, 31). ABU, on the other
hand, is an asymptomatic carrier state in which patients may
carry 105 CFU/ml of a single E. coli strain for years without
provoking a host response. In early studies, this was explained
by a lack of virulence genes; however, molecular epidemiology
has shown that60% of ABU strains carry virulence genes but
fail to express the phenotype (18, 19).
The ability of UPEC to cause symptomatic UTI is enhanced
by adhesins, including type 1 and P fimbriae (11, 17). P fim-
briae enhance the establishment of bacteriuria and activate the
innate immune response in animal models and in the human
urinary tract (2, 20, 21, 33, 35, 36). Binding is mediated by the
PapG adhesin, which is located at the tips of the fimbriae and
which recognizes the -D-galatopyranosyl-(1-4)--D-galacto-
pyranoside receptor epitope in the globoseries of glycolipids
(3, 12, 13). Type 1 fimbriae enhance colonization, induce host
responses in the murine UTI model, and promote biofilm
formation and invasion (4, 14, 16, 23). Receptor binding is also
mediated by an adhesin located at the tips of the fimbriae
(FimH) that binds to -D-mannosylated proteins, such as uro-
plakins, which are abundant in the bladder (32). In this study,
we characterized the type 1- and P-encoding fimbrial genes
from the prototypical ABU strain E. coli 83972. The strain is a
clinical isolate capable of long-term bladder colonization (1). It
was isolated from a patient with ABU who had carried it for 3
years, and it has been used in colonization studies as a pro-
phylactic agent to prevent UTI in humans (2, 8, 30, 34, 35).
E. coli 83972 does not express a detectable type 1 fimbrial
phenotype when recovered from the urinary tract or after in
vitro subculture (35). However, previous genetic analysis of the
strain revealed that it contains the genes for type 1 fimbriae
(9). To examine the E. coli 83972 type 1 fimbria-encoding
genes in more detail, we performed a series of Southern hy-
bridizations with probes spanning different regions within the
MG1655 type 1 fimbrial gene cluster. A positive hybridization
signal was obtained with a fimH gene probe but not with fimE
or fimAIC probes (Fig. 1). Subsequent PCR amplification and
sequencing of the fim cluster from E. coli 83972 revealed a
4.25-kb deletion affecting all genes except those encoding the
minor components fimF, fimG, and fimH (Fig. 1). The chro-
mosomally located fimH gene was expressed as a functional
product, since the transformation of E. coli 83972 with plasmid
pPKL114 (containing fimBEAICDFG) induced a mannose-
sensitive agglutination of yeast cells (Table 1). Sequencing of
the fimH gene from E. coli 83972 revealed the following
changes relative to FimH from E. coli K-12: V48A, G87S,
N91S, and S99N.
E. coli 83972 reportedly contains pap gene sequences (9) but
has never been shown to express P fimbriae. However, when
we grew 83972 on a solid medium and examined the cells by
transmission electron microscopy, we observed that the major-
ity produced fimbriae (Fig. 2A). Interestingly, very few cells
produced fimbriae when grown as liquid cultures. Purification
and sodium dodecyl sulfate-polyacrylamide gel electrophoresis
analysis of the fimbriae revealed a prominent 18-kDa protein
that was confirmed by N-terminal amino acid sequencing to be
the PapA major subunit (Fig. 2B). E. coli 83972 cells express-
ing these P fimbriae did not hemagglutinate human red blood
cells (RBCs), bind to human uroepithelial cells, or bind to
Gal1-4Gal-containing glycolipids (data not shown). Thus,
strain 83972 produces P fimbriae that are unable to bind to any
known receptor targets.
The pap gene cluster of E. coli 83972 was amplified by PCR
and sequenced. A comparison of the amino acid sequence
deduced from each gene with the equivalent genes from UPEC
CFT073 revealed that the greatest divergence occurred in
papA, papE, and papG (Fig. 2E). The function of the 83972
PapG adhesin was assessed by complementation with the fol-
lowing plasmids: (i) pDD3 (all pap genes from UPEC J96
except papG) and (ii) pDD4 (papG from UPEC J96). Only E.
coli 83972 (pDD4) cells readily agglutinated RBCs and bound
to human uroepithelial cells (Fig. 3A and B; Table 1). Thus,
the recognition of receptor targets by the P fimbriae of E. coli
83972 can be complemented in trans by a plasmid carrying a
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functional papG gene. Western blot analysis of fimbrial pro-
teins using PapG-specific polyclonal antisera revealed that
PapG is expressed and suggests that it is incorporated into the
fimbrial structure (Fig. 2C). This interpretation is supported by
the fact that E. coli 83972 produces fimbriae of normal length
and morphology (previous studies of fimbrial biogenesis have
demonstrated that disruption of the adhesin-encoding gene
results in the synthesis of organelles of aberrant length and
morphology) (24). It is possible that the lack of function of
PapG may be associated with minor amino acid changes in the
protein sequence. In this respect, all but one of the residues
predicted to contribute to the PapG binding site (5) are con-
served in the E. coli 83972 PapG sequence (Fig. 4). By analogy
with the FimH adhesin (22, 25), variations that alter the con-
FIG. 1. (A) Physical map of the fim gene cluster from E. coli MG1655 indicating the arrangement of the genes, the position of relevant
restriction enzyme sites (E, EcoRI; EV, EcoRV), and the region covered by each of the probes. (B) Southern blot analysis of total genomic DNA
from E. coli MG1655 and 83972 digested to completion with either EcoRI or EcoRV and probed with the fimE gene, the fimA, fimB, and fimC
genes, and the fimH gene (as indicated). The sizes of the hybridizing fragments are indicated in kilobase pairs. (C) Structure of the fim locus in
E. coli 83972 indicating the precise start and end points of the deletion between fimB and fimD.
TABLE 1. Agglutination profile of LB agar-grown E. coli 83972
containing plasmid-borne encoded fimbrial genes
Plasmid
Agglutination of a:
Yeast cells Human typeA RBC
None  
pPKL4 (all fim genes)  
pPKL114 (all fim genes except fimH)  
pPAP5 (all pap genes from J96)  
pDD3 (all pap genes except papG)  
pDD4 (papG only)  
a , negative; , positive.
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formational stability of the protein loops that carry the recep-
tor-interacting residues may also account for its lack of function.
E. coli 83972 was carried by a young girl for 3 years without
any symptoms. Whether the strain had already lost the ability
to express P and type 1 fimbriae previously during passage
through another host or did so in this particular girl is unclear.
However, several lines of evidence support the notion that the
ancestor of E. coli 83972 was a pyelonephritic UPEC strain: (i)
the FimH allele of 83972 contains minor amino acid variations
that are consistent with those of previously characterized pye-
lonephritis strains (26–28); (ii) the strain is able to express P
fimbriae, albeit an apparently nonadhesive type; (iii) multilocus
sequence typing of 83972 shows that it belongs to the B2 clonal
group (http://www.mlst.net/) and this group contains E. coli
strains associated with pyelonephritis and other extraintestinal
invasive clinical syndromes such as bacteremia, prostatitis, and
meningitis; and (iv) the strain possesses the F14 PapA allele,
which has been associated with other virulence factors, includ-
ing S and F1C fimbriae, hemolysin, and cytotoxic necrotizing
factor 1 from E. coli B2 strains (10). Genes of nonfunctional
products tend to erode over time through accumulation of
mutations, and there are many instances where genome shrink-
age has been associated with bacterial lifestyle transition (15).
In E. coli 83972, the two primary adhesive organelles associ-
ated with uropathogenesis have been inactivated by adaptive
mutations as a trade-off with the host.
FIG. 2. (A) Transmission electron micrographs of E. coli 83972 grown (i) in LB broth and (ii) on LB agar. Almost all cells harvested after
growth on agar produced P fimbriae, while less than 5% of cells grown as liquid cultures produced any fimbriae. This may explain previous
observations that E. coli 83972 does not produce fimbriae. (B) Sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis of purified
fimbrial proteins from E. coli 83972 (lane 2). The N-terminal amino acid sequence of the PapA fimbrial protein is indicated in brackets. Molecular
size markers (lane 1) are 250, 98, 64, 50, 36, 30, 16, and 6 kDa. (C) Corresponding Western blot analysis of the same purified fimbrial preparation
using a PapG-specific polyclonal antiserum indicating the expression of the PapG adhesin. (D) Physical map of the pap gene cluster from E. coli
83972 indicating the arrangement of the genes and the amino acid identity of each of the predicted proteins with the respective protein from E.
coli CFT073. The predicted translational product of the papA gene is identical to the first 10 residues identified by N-terminal sequencing. PapA
belongs to the F14 allele group, while PapG belongs to the class III allele group (nucleotide accession number, DQ010312).
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The characterization of the fim- and pap-encoding genes in
this study illustrates an important issue with regard to the
current molecular knowledge of E. coli 83972. Previous studies
demonstrating the presence of these genes in E. coli 83972
failed to correlate with its phenotypic characteristics (9, 33).
Here we have shown for the first time that E. coli 83972
contains only some of the type 1 fimbrial genes and is not
capable of producing these organelles. The finding that fimH is
functional and constitutively expressed may explain a previous
report that identified a clone capable of mannose-sensitive
hemagglutination from a recombinant cosmid library derived
from 83972 (9). In the case of P fimbriae, these organelles are
expressed, but their function remains unknown since they do
not bind to defined receptor targets. This study sheds new light
on how E. coli 83972 has adapted to grow in the human blad-
der. The strain has lost the ability to express functional P and
type 1 fimbriae and is thus able to persist in this environment
without triggering a host immune response. In contrast to
organisms that have acquired genes for pathogenesis, E. coli
83972 is an example of an organism that has adapted to com-
mensalism through gene loss and mutation.
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